Common misconceptions about levocarnitine and dialysis [1]

Seminars in Dialysis

Volumn 18, Issue 4, 2005, Pages 349-351

  Schreiber, Brian ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARNITINE;

HUMAN; LETTER; RENAL REPLACEMENT THERAPY;

CARNITINE; HUMANS; RENAL DIALYSIS;

EID: 23844556828     PISSN: 08940959     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2005.18412.x     Document Type: Letter

References (16)

1. Steinman TI: L-carnitine supplementation in dialysis patients: does the evidence justify its use? Semin Dial 18:1-2, 2005
2. Decision Memorandum, Medicare Coverage Policy, Levocarnitine for End Stage Renal Disease (CAG-00077N), 2002, available at http://cms.hhs.gov/ coverage/8b3-uu2.asp
3. Hurot JM, Cucherat M, Haugh M, Fouque D: Effects of L-carnitine supplementation in maintenance hemodialysis patients: a systematic review. J Am Soc Nephrol 13:708-714, 2002
4. Caruso U, Leone L, Cravotto E, Nava D: Effects of L-carnitine on anemia in aged hemodialysis patients treated with recombinant human erythropoietin: a pilot study. Dial Transplant 27:498-506, 1998
5. Kletzmayr J, Mayer G, Legenstein E, Heinz-Peer G, Leitha T, Horl WH, Kovarik J: Anemia and carnitine supplementation in hemodialyzed patients. Kidney Int Suppl 69:S93-S106, 1999
6. Labonia WD: L-carnitine effects on anemia in hemodialyzed patients treated with erythropoietin. Am J Kidney Dis 26:757-764, 1995
7. Fornasini GF, Evans A: Analysis of free carnitine in plasma of ESRD patients undergoing chronic dialysis: what is the best assay? Dial Transplant 32(6suppl 1):S1-S12, 2003
8. Evans AM, Faull RJ, Nation RL, Prasad S, Elias T, Reuter SE, Fornasini G: Impact of hemodialysis on endogenous plasma and muscle carnitine levels in patients with end stage renal disease. Kidney Int 66:1527-1534, 2004
9. Kobayashi A, Fujisawa S: Effect of L-carnitine on mitochondrial acyl CoA esters in the ischemic dog heart. J Mol Cell Cardiol 26:499-508, 1994
10. Ifudu O, Uribarri J, Rajwani I, Vlacich V, Reydel K, Delosreyes G, Friedman EA: Low hematocrit may connote a malnutrition/inflammation syndrome in hemodialysis patients. Dial Transplant 31:845-878
11. Vesela E, Racek J, Trefil L, Jankovy'ch V, Pojer M: Effect of L-carnitine supplementation in hemodialysis patients. Nephron 88:218-223, 2001
12. Bellinghieri G, Santoro D, Calvani M, Savica V: Role of carnitine in modulating acute-phase protein synthesis in hemodialysis patients. J Renal Nutr 15:13-17, 2005
13. Poldermans D, Man in T Veld AJ, Rambaldi R, Van Den Meiracker AH, Van Den Dorpel MA, Rocchi G, Boersma E, Bax JJ, Weimar W, Roelandt JR, Zietse R: Cardiac evaluation in hypotension-prone and hypotension-resistant hemodialysis patients. Kidney Int 56:1905-1911, 1999
14. Furukawa K, Ikeda S, Naito T, Miyahara Y, Iwasaki T, Matsushita T, Yakabe K, Yamaguchi K, Shikuwa M, Muraya Y, Kohno S: Cardiac function in dialysis patients evaluated by Doppler echocardiography and its relation to intradialytic hypotension: a new index combining systolic and diastolic function. Clin Nephrol 53:18-24, 2000
15. van Es A, Henny FC, Kooistra MP, Lobatto S, Scholte HR: Amelioration of cardiac function by L-carnitine administration in patients on haemodialysis. Contrib Nephrol 98:28-35, 1992
16. Romagnoli GF, Nasco A, Carraro G, Lidestri V: Beneficial effects of L-carnitine in dialysis patients with impaired left ventricular function: an observational study. Curr Med Res Opin 18:172-175, 2002